Health Products
Health Products
| No. | Title | Status | Download |
|---|---|---|---|
| 11 | Notification of the Food and Drug Administration Re: Guidelines for the Registration of Modern Drugs for Human Use and Amendments to the Drug Registration through the Reference of Evaluation Results from the Collaborative Registration Procedure (CRP) | ||
| 12 | Notification of the Ministry of Public Health Re: Rules, Procedures and Conditions for Modern Drug Distribution, B.E. 2564 (2021)* | ||
| 13 | Notification of the Food and Drug Administration Re: Guidelines for the Consideration of Low-Risk Medicinal Product Registrations | ||
| 14 | Ministerial Regulation on Renewal of Drug Formula Registration Certificates, B.E. 2566 (2023)* | ||
| 15 | Notification of the Food and Drug Administration Re: Guidelines for the Consideration of Applications for Modern Drug Registrations Submitted through Electronic Means (No.2) | ||
| 16 | Notification of the Food and Drug Administration Re: Guidelines for the Consideration of Applications for Modern Drug Registrations Submitted through Electronic Means | ||
| 17 | Notification of the Ministry of Public Health Re: Rules, Procedures and Conditions for Herbal Product Importation and Sale, B.E. 2566 (2023)* | ||
| 18 | Notification of the Ministry of Public Health Re: Type 1, Type 2, Type 4, and Type 5 Narcotic Transit Inspection, B.E. 2567 (2024)* | ||
| 19 | Ministerial Regulation No. 24 (B.E. 2537 (1994)) Issued under the Drugs Act, B.E. 2510 (1967)* | ||
| 20 | Notification of the Food and Drug Administration Re: Prescribing the Psychotropic Substance Inspection Form in The Case of Import, Export or Transit |
